Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise:

Antiplatelet

Job title: Professor and Chair of Pharmacology
Bianca Rocca, MD, PhD, FESC is Professor of Pharmacology at the Libera Università Mediterranea-LUM (Casamassima, Bari, Italy).She trained as a Postdoctoral Fellow at the University of Pennsylvania (Philadelphia, US), and as a haematologist (speciality board at the Catholic University School of Medicine, Rome, Italy).She is a Fellow of the European Society of Cardiology (FESC), and has served as… View more
Author(s): Mandeep Mehra , Christian Inchaustegui Added: 2 years ago
AHA 2023 - Investigator, Dr Mandeep Mehra (Brigham and Women's Hospital, US) is interviewed by Dr Christian Inchaustegui (Oregon Health & Science University, US), CardioNerds Ambassador, on the findings of the ARIES HM3 trial (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES… View more
Author(s): Harriette Van Spall , Mandeep Mehra Added: 2 years ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were… View more
Author(s): Finn Gustafsson Added: 1 year ago
HFA 24 - Dr Finn Gustafsson (Rigshospitalet, DK) joined us onsite at the Heart Failure Association Congress to discuss the findings from a subanalysis of the ARIES HeartMate 3 study (NCT04069156).ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were treated with two… View more
Job title: Director of Cardiology
Research Area(s) / Expertise:

Atrial Arrhythmias

Atrial Fibrillation

Catheter Ablation of Cardiac Arrhythmias

Stroke

Prof Boyoung Joung is the Professor of Internal Medicine at theYonsei University in Seoul, South Korea. His research interests include atrial fibrillation, stroke, hypertension, and antithrombotic therapy. Prof Joung is a member of theArrhythmia & Electrophysiology Revieweditorial board. View more
Job title: Division of Cardiology, Department of Internal Medicine II
DrNiessner works in the Division of Cardiology, Department of Internal Medicine II atMedical University of Vienna, Vienna, Austria. His research topics include inflammation in cardiovascular diseases, antithrombotic therapy, translational research, and biomarkers and personalized medicine. View more
Job title: Head of Clinical and Experimental Cardiology
Prof Eliano Navarese is an Interventional Cardiologist, Associate Professor and Head of Clinical and Experimental Cardiology at the University of Sassari, Sardinia Island in Italy.His expertise is in the fields of interventional cardiology, coronary artery disease, antithrombotics, lipid-lowering therapies, cardiovascular pharmacotherapy, clinical trials and evidence-based medicine. View more
Research Area(s) / Expertise:

Expertise

Job title: Prof. Johanne Silvain is professor of medicine at the Pierre and Marie Curie University in Paris, France.
He is an interventional cardiologist, with experience in coronary angioplasty and OTC, and is Director of the Coronary Intensive Care Unit.He is licensed at the University of Medicine of Paris (UPMC) and is the author of over 100 publications in prestigious authoritative journals.The research interests of Dr. Silvain fall within the field of thrombosis (composition of thrombi) and antithrombotic… View more
Research Area(s) / Expertise:

Expertise

Job title: Professor of Medicine
Prof Duk-Woo Park is Professor in the Cardiovascular Medicine Division at Asan Medical Center, Seoul, Korea, and an Instructor in Medicine at the University of Ulsan College of Medicine.Prof Park has a particular interest in revascularization strategy (PCI vs. CABG for multivessel and left main disease), antiplatelet/antithrombotic strategey, transcatheter valve interventions (TAVR), major… View more